Risk Management: Prescribing Controlled Substances: Managing the Risks

| April 1, 2018 | 0 Comments

by Donna Vanderpool, MBA, JD

Ms. Vanderpool is Vice President, Risk Management at PRMS, Inc. in Arlington, Virginia.

Innov Clin Neurosci. 2018;15(3–4):47–51

Funding: No funding was provided for the preparation of this article.

Disclosures: The authors have no conflicts of interest relevant to the content of this article.

Abstract: This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. We invite questions from our readers. The answers are provided by PRMS, Inc. (www.prms.com), a manager of medical professional liability insurance programs with services that include risk management consultation, education and onsite risk management audits, and other resources to healthcare providers to help improve patient outcomes and reduce professional liability risk. The answers published in this column represent those of only one risk management consulting company. Other risk management consulting companies or insurance carriers may provide different advice, and readers should take this into consideration. The information in this column does not constitute legal advice. For legal advice, contact your personal attorney. Note: The information and recommendations in this article are applicable to physicians and other healthcare professionals so “clinician” is used to indicate all treatment team members.


The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Category: Past Articles, Risk Management

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.